Tarsus Pharmaceuticals Inc's Customers Performance

Name: Tarsus Pharmaceuticals Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

TARS

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


TARS's Source of Revenues		During the corresponding time, Tarsus Pharmaceuticals Inc recorded a revenue increase by 69.41 % year on year, sequentially revenue grew by 7.32 %. While revenue at the Tarsus Pharmaceuticals Inc 's corporate clients • List of TARS Customers

for the same period Tarsus Pharmaceuticals Inc recorded revenue increase by 69.41 % year on year, sequentially revenue grew by 7.32 %.

• List of TARS Customers

Tarsus Pharmaceuticals Inc's Business Units


Product	183.6 %	of total Revenue
License fees and collaboration revenue Reportable Segment	9.58 %	of total Revenue
Reportable	193.18 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Tarsus Pharmaceuticals Inc's Comment on Sales, Marketing and Customers

The company serves customers in the healthcare industry who bill federal programs for products. Its markets include healthcare providers, health plans, healthcare clearinghouses, physicians, teaching hospitals, and other practitioners. The company’s market segments encompass federal healthcare programs such as Medicare, Medicaid, and the Children’s Health Insurance Program, as well as non-government health benefit programs and private insurers.

Tarsus Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers

TARS's Stock Performance relative to it's Customers

TARS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Tarsus Pharmaceuticals Inc	3,939.27	565.30	-49.97	370
SUBTOTAL	0.00	0.00	0.00	-

Sources: Tarsus Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Tarsus Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Tarsus Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.